28 Jun Novacyt Announces Acquisition of Infectious Disease Business from Omega Diagnostics
Acquisition of ID business from Omega Diagnostics Accelerating profitability by expanding the Lab21 business with complimentary products...
19 Jun Update on unsecured debt facility
Update on unsecured debt facility Paris, France and Camberley, UK – 19 June 2018 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the conversion of...
12 Jun RESULTS OF ANNUAL GENERAL MEETING
AGM results statement June 2018 Paris, France and Cambridge, UK – 12 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, yesterday held its Annual...
05 Jun NOVACYT LAUNCHES NEW PRODUCT IN INFECTIOUS MONONUCLEOSIS
New product launch under PathFlow brand First in a series of new product launches in infectious diseases...
30 May Novacyt secures €4.0m funding through unsecured debt facility to support M&A strategy
Novacyt Funding Paris, France and Camberley, UK – 30 May 2018 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that on 29...
23 May Publication of Annual Report and Notice of AGM
Posting of AR and Notice of AGM FINAL Paris, France and Camberley, UK – 23 May 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today...
15 May Primerdesign’s quality control: The what’s and why’s of ISO certification
Quality is paramount to Primerdesign’s success and reputation. It is critical that customers are confident in the quality and performance of our products. By promoting a culture of improvement, accountability...
26 Apr NOVACYT FULL YEAR 2017 RESULTS
Novacyt FY17 financial results Record revenue growth of 35% Significantly narrowed losses Positive outlook for 2018...
23 Apr An innovative approach to qPCR multiplexing: A Q+A with Sara Arocas-Torrecillas
Primerdesign is proud to present three brand new real-time PCR product ranges to our portfolio. Firstly, genesigMYPLEX qPCR Kit STD is a personalised approach to multiplex assays. You have full...
22 Mar NOVACYT SIGNS ASSAY DEVELOPMENT CONTRACT FOR DIAGNOSIS OF RESPIRATORY INFECTIONS WITH GENEPOC
Further validation of Novacyt’s expertise in developing assays for clinical applications Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC Paris, France and Camberley, UK – 22 March 2018 –...